Ernexa Therapeutics Inc. ERNA
1.95 USD -0.05 -2.50%
As of Nov 2, 10:06 AM ET
- YTD
- -93.50%
- 1 year
- -95.85%
- Open
- 2.04
- Prev close
- 2.00
- Mkt cap
- 3.15M
- Vol
- 2.77K
- Avg vol
- 50.30K
- EPS
- -13.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.93
- High
- 2.04
- Forward P/E
- -0.03
- Beta
- 7.77
- Short ratio
- 1.07
- Inst. own
- 11.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.7302
- 200-d avg
- 1.58
- 1y target
- 0.00
5Y chart
Chart tools
Chart is warming up
The five-year price history for ERNA has not been loaded yet. Try again in a moment.
Altman Z-Score
-64.60 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
P/E -0.5×
P/S 0.0×
P/B 3.2×
P/FCF -1.1×
EV/EBITDA -0.4×
EV/Sales 0.0×
FCF Yield -93.2%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -586.6%
ROIC -316.6%
ROA -241.4%
Revenue -100.0%
Operating Income 40.5%
EPS (diluted) -42.7%
Free Cash Flow 56.5%
Current Ratio 1.0×
Quick Ratio 1.0×
Debt / Equity 0.2×
Net Debt / EBITDA 0.1×
Interest Coverage -345×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31